PriceTargets.com logo

Cardinal Health - CAH Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $82.23
  • Forecasted Upside: -2.08%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$83.98 As of 06/2/2023 12:10 PM ET
▲ +0.56 (0.67%)

This chart shows the closing price for CAH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cardinal Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CAH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CAH

Analyst Price Target is $82.23
▼ -2.08% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $82.23, with a high forecast of $94.00 and a low forecast of $72.00. The average price target represents a -2.08% upside from the last price of $83.98.

This chart shows the closing price for CAH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in Cardinal Health. This rating has held steady since July 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
3/4/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
6/2/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/8/2023Deutsche Bank AktiengesellschaftBoost Target$88.00 ➝ $90.00Low
5/5/2023UBS GroupBoost Target$91.00 ➝ $93.00Low
5/5/2023BarclaysBoost Target$77.00 ➝ $80.00Low
4/26/2023Deutsche Bank AktiengesellschaftBoost Target$77.00 ➝ $88.00Low
3/31/2023CitigroupInitiated CoverageNeutral$77.00Low
3/22/2023Deutsche Bank AktiengesellschaftLower TargetHold$82.00 ➝ $77.00Low
2/3/2023Morgan StanleyBoost TargetOverweight$86.00 ➝ $90.00Low
2/3/2023Credit Suisse GroupBoost TargetNeutral$89.00 ➝ $92.00Low
2/3/2023Robert W. BairdUpgradeNeutral ➝ Outperform$87.00 ➝ $94.00Low
1/31/2023UBS GroupBoost TargetBuy$78.00 ➝ $91.00Low
1/6/2023Morgan StanleyBoost TargetOverweight$82.00 ➝ $86.00Low
11/22/2022Credit Suisse GroupBoost TargetNeutral$64.00 ➝ $79.00Low
11/14/2022MizuhoBoost TargetNeutral$66.00 ➝ $74.00Low
11/7/2022Morgan StanleyBoost TargetOverweight$76.00 ➝ $82.00Low
11/7/2022Robert W. BairdBoost TargetNeutral$74.00 ➝ $82.00Low
11/4/2022Bank Of America (Bofa)UpgradeUnderperform ➝ Neutral$64.00 ➝ $80.00Low
11/4/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$64.00 ➝ $80.00Low
10/13/2022Robert W. BairdBoost Target$74.00Low
8/29/2022UBS GroupBoost TargetBuy$61.00 ➝ $78.00Low
8/22/2022Morgan StanleyBoost TargetOverweight$70.00 ➝ $76.00Low
8/16/2022CowenBoost TargetMarket Perform$59.00 ➝ $72.00Low
8/16/2022CowenBoost TargetMarket Perform$59.00 ➝ $72.00Low
8/15/2022Evercore ISIBoost Target$75.00Low
8/15/2022BarclaysBoost Target$67.00Low
8/12/2022MizuhoBoost Target$58.00 ➝ $66.00Low
8/12/2022Credit Suisse GroupBoost TargetNeutral$56.00 ➝ $64.00Low
8/12/2022Robert W. BairdBoost TargetNeutral$57.00 ➝ $73.00Low
7/14/2022Morgan StanleyLower TargetOverweight$74.00 ➝ $70.00Low
5/26/2022BarclaysDowngradeOverweight ➝ Equal Weight$70.00 ➝ $64.00Low
5/18/2022Evercore ISIUpgradeIn-Line ➝ Outperform$55.00 ➝ $68.00Medium
4/12/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$74.00Medium
2/4/2022Credit Suisse GroupLower TargetNeutral$60.00 ➝ $58.00Low
2/4/2022Robert W. BairdBoost Target$52.00 ➝ $57.00Low
1/11/2022BarclaysLower TargetOverweight$65.00 ➝ $63.00High
12/17/2021Morgan StanleyLower TargetEqual Weight$64.00 ➝ $54.00Medium
11/15/2021Credit Suisse GroupLower TargetNeutral$53.00 ➝ $50.00Low
11/12/2021Deutsche Bank AktiengesellschaftBoost TargetHold$51.00 ➝ $59.00High
11/10/2021MizuhoLower TargetNeutral$56.00 ➝ $53.00Medium
11/10/2021BarclaysLower TargetOverweight$68.00 ➝ $65.00Medium
8/6/2021Evercore ISIReiterated RatingHold$50.00Low
8/6/2021BarclaysLower TargetOverweight$71.00 ➝ $68.00Low
8/6/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$62.00 ➝ $51.00Low
8/5/2021CitigroupDowngradeBuy ➝ Underperform$69.00 ➝ $56.00High
8/5/2021Bank of AmericaDowngradeBuy ➝ Underperform$69.00 ➝ $56.00High
7/13/2021Deutsche Bank AktiengesellschaftSet TargetBuy$57.44Low
5/17/2021Robert W. BairdReiterated RatingOutperform ➝ Neutral$66.00 ➝ $64.00Low
5/10/2021Robert W. BairdDowngradeOutperform ➝ Neutral$66.00 ➝ $64.00Low
3/3/2021Morgan StanleyLower TargetEqual Weight$66.00 ➝ $64.00Low
1/8/2021Wolfe ResearchUpgradeUnderperform ➝ Peer PerformMedium
11/13/2020MizuhoBoost TargetNeutral$56.00 ➝ $59.00Low
11/9/2020Morgan StanleyBoost TargetEqual Weight$61.00 ➝ $66.00Low
11/6/2020Robert W. BairdBoost TargetOutperform$64.00 ➝ $70.00Low
11/6/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$61.00 ➝ $65.00Low
11/2/2020BarclaysUpgradeEqual Weight ➝ Overweight$57.00High
9/25/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$66.00 ➝ $61.00High
8/10/2020UBS GroupLower TargetBuy$65.00 ➝ $64.00Low
8/7/2020Morgan StanleyBoost TargetEqual Weight$59.00 ➝ $61.00Low
7/21/2020Bank of AmericaBoost TargetBuy$61.00 ➝ $63.00Medium
7/20/2020GuggenheimUpgradeNeutral ➝ BuyHigh
6/15/2020Morgan StanleyBoost TargetEqual Weight$57.00 ➝ $59.00High
5/15/2020Bank of AmericaUpgradeBuyHigh
5/15/2020UBS GroupUpgradeNeutral ➝ Buy$48.00 ➝ $64.00High
5/12/2020MizuhoBoost TargetNeutral$50.00 ➝ $56.00Medium
5/12/2020Morgan StanleyBoost TargetEqual Weight$51.00 ➝ $57.00High
5/11/2020CfraLower TargetHold$61.00 ➝ $58.00Low
4/22/2020Credit Suisse GroupDowngradeHold$53.00Low
3/27/2020Morgan StanleyLower TargetEqual Weight$64.00 ➝ $51.00Low
3/20/2020Bank of AmericaUpgradeUnderperform ➝ Buy$57.00 ➝ $58.00High
2/12/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight$48.00 ➝ $64.00Low
2/7/2020MizuhoBoost TargetNeutral$52.00 ➝ $58.00Low
2/7/2020Robert W. BairdUpgradeNeutral ➝ Outperform$54.00 ➝ $68.00Low
2/6/2020CfraBoost TargetHold$56.00 ➝ $61.00High
1/19/2020BarclaysReiterated RatingHold$54.00Low
12/16/2019GuggenheimDowngradeBuy ➝ NeutralMedium
9/12/2019GuggenheimSet TargetBuy$55.00Low
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$50.00Low
9/6/2019Morgan StanleyLower TargetUnderweight$50.00 ➝ $41.00N/A
8/27/2019ArgusDowngradeBuy ➝ HoldHigh
8/20/2019GuggenheimUpgradeNeutral ➝ Buy$50.00 ➝ $52.00Medium
4/17/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$51.00High
4/2/2019Wolfe ResearchInitiated CoverageUnderperformHigh
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$51.00Low
12/3/2018Morgan StanleyBoost TargetUnderweight ➝ Underweight$40.00 ➝ $50.00Low
11/16/2018SVB LeerinkDowngradeOutperform ➝ Market Perform$55.00High
11/14/2018Jefferies Financial GroupReiterated RatingHold$61.00Low
11/9/2018Royal Bank of CanadaSet TargetHold$57.00Low
9/21/2018Royal Bank of CanadaSet TargetHold$60.00High
8/12/2018MizuhoReiterated RatingHold$53.00Low
8/7/2018Robert W. BairdLower TargetNeutral ➝ Neutral$51.00 ➝ $50.00Low
8/7/2018Royal Bank of CanadaReiterated RatingHold$56.00Medium
7/20/2018Robert W. BairdReiterated RatingHold$51.00Low
7/16/2018ArgusLower TargetBuy ➝ Buy$85.00 ➝ $75.00Low
7/3/2018Morgan StanleyLower TargetUnderweight ➝ Underweight$55.00 ➝ $40.00Medium
(Data available from 6/2/2018 forward)

News Sentiment Rating

0.88 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/4/2022
  • 5 very positive mentions
  • 25 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
12/4/2022
  • 11 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
1/3/2023
  • 24 very positive mentions
  • 22 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2023
  • 23 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 4 very negative mentions
Mentions as of
3/4/2023
  • 20 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2023
  • 18 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
5/3/2023
  • 28 very positive mentions
  • 24 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
6/2/2023

Current Sentiment

  • 28 very positive mentions
  • 24 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Cardinal Health logo
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.
Read More

Today's Range

Now: $83.98
Low: $83.27
High: $84.36

50 Day Range

MA: $81.04
Low: $70.37
High: $86.56

52 Week Range

Now: $83.98
Low: $49.70
High: $87.03

Volume

551,229 shs

Average Volume

2,369,108 shs

Market Capitalization

$21.38 billion

P/E Ratio

48.26

Dividend Yield

2.44%

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Cardinal Health?

The following Wall Street sell-side analysts have issued research reports on Cardinal Health in the last twelve months: Bank Of America (Bofa), Bank of America Co., Barclays PLC, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Mizuho, Morgan Stanley, Robert W. Baird, StockNews.com, TheStreet, and UBS Group AG.
View the latest analyst ratings for CAH.

What is the current price target for Cardinal Health?

13 Wall Street analysts have set twelve-month price targets for Cardinal Health in the last year. Their average twelve-month price target is $82.23, suggesting a possible downside of 1.3%. Robert W. Baird has the highest price target set, predicting CAH will reach $94.00 in the next twelve months. Cowen Inc. has the lowest price target set, forecasting a price of $72.00 for Cardinal Health in the next year.
View the latest price targets for CAH.

What is the current consensus analyst rating for Cardinal Health?

Cardinal Health currently has 8 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CAH, but not buy more shares or sell existing shares.
View the latest ratings for CAH.

What other companies compete with Cardinal Health?

Other companies that are similar to Cardinal Health include AmerisourceBergen, McKesson, BeiGene, argenx and Baxter International. Learn More about companies similar to Cardinal Health.

How do I contact Cardinal Health's investor relations team?

Cardinal Health's physical mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company's listed phone number is (614) 757-5000 and its investor relations email address is [email protected]. The official website for Cardinal Health is www.cardinalhealth.com. Learn More about contacing Cardinal Health investor relations.